There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

The subcutaneous implantable cardioverter–defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and ...

Add Yahoo as a preferred source to see more of our stories on Google. Electrocardiograms, or ECGs, record the electrical activity of your heart. Randy Faris/The Image Bank via Getty Images Your ...

Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared an antibiotic-eluting envelope to reduce complications after pacemaker or defibrillator implant.

Some portable tech devices equipped with powerful magnets can interfere with your heart implant's ability to regulate dangerous irregular heart rhythms, a new study reports. Swiss researchers found ...

High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications with a type of device implanted under the skin, a Canadian study has found. Traditional ...

BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up.